ZA903535B - Stable solutions of rebeccamycin analog and preparation thereof - Google Patents

Stable solutions of rebeccamycin analog and preparation thereof

Info

Publication number
ZA903535B
ZA903535B ZA903535A ZA903535A ZA903535B ZA 903535 B ZA903535 B ZA 903535B ZA 903535 A ZA903535 A ZA 903535A ZA 903535 A ZA903535 A ZA 903535A ZA 903535 B ZA903535 B ZA 903535B
Authority
ZA
South Africa
Prior art keywords
rebeccamycin
acid
stable solutions
preparation
diethylaminoethyl
Prior art date
Application number
ZA903535A
Other languages
English (en)
Inventor
Ubrani V Venkataram
V Venkataram Ubrani
Miriam K Franchini
K Franchini Miriam
Joseph B Bogardus
B Bogardus Joseph
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ZA903535B publication Critical patent/ZA903535B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
ZA903535A 1989-05-10 1990-05-09 Stable solutions of rebeccamycin analog and preparation thereof ZA903535B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/349,608 US5496809A (en) 1989-05-10 1989-05-10 Stable solutions of rebeccamycin analog

Publications (1)

Publication Number Publication Date
ZA903535B true ZA903535B (en) 1991-01-30

Family

ID=23373191

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA903535A ZA903535B (en) 1989-05-10 1990-05-09 Stable solutions of rebeccamycin analog and preparation thereof

Country Status (25)

Country Link
US (1) US5496809A (fr)
EP (1) EP0397147B1 (fr)
JP (1) JPH0643437B2 (fr)
KR (1) KR920004098B1 (fr)
CN (1) CN1054510C (fr)
AT (1) ATE117313T1 (fr)
AU (1) AU618896B2 (fr)
CA (1) CA2015632C (fr)
CZ (1) CZ283416B6 (fr)
DE (1) DE69016087T2 (fr)
DK (1) DK0397147T3 (fr)
EG (1) EG19218A (fr)
ES (1) ES2066902T3 (fr)
FI (1) FI95777C (fr)
GR (1) GR3015714T3 (fr)
HK (1) HK1005033A1 (fr)
HU (1) HU206627B (fr)
IE (1) IE66515B1 (fr)
IL (1) IL94312A (fr)
NO (1) NO176390C (fr)
PT (1) PT93991B (fr)
RU (1) RU2053766C1 (fr)
TW (1) TW202390B (fr)
YU (1) YU90490A (fr)
ZA (1) ZA903535B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2125976T3 (es) * 1992-03-20 1999-03-16 Wellcome Found Otros derivados de indol con accion antiviral.
US5968961A (en) * 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
WO1998019707A1 (fr) * 1996-11-05 1998-05-14 Alcon Laboratories, Inc. Acides polyhydroxy monocarboxyliques et dicarboxyliques et leurs lactones dans des compositions ophtalmiques
US20040048012A1 (en) * 1996-11-18 2004-03-11 Weder Donald E. Polymeric materials having a matte finish on a surface thereof
CA2241609C (fr) * 1997-06-26 2009-08-25 Southpac Trust International, Inc. Matiere polymere ayant l'apparence d'un tissu
CN100344285C (zh) * 2005-02-03 2007-10-24 宋艳 多潘立酮水溶性制剂及其制备方法
JP4822151B2 (ja) * 2005-02-14 2011-11-24 山本光学株式会社 眼鏡保持バンドおよびその保持バンド付き眼鏡

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
US4808613A (en) * 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition

Also Published As

Publication number Publication date
IL94312A (en) 1994-02-27
HK1005033A1 (en) 1998-12-18
CA2015632C (fr) 1998-01-27
CN1054510C (zh) 2000-07-19
ES2066902T3 (es) 1995-03-16
CA2015632A1 (fr) 1990-11-10
IL94312A0 (en) 1991-03-10
EP0397147A3 (fr) 1991-06-12
AU618896B2 (en) 1992-01-09
US5496809A (en) 1996-03-05
NO176390B (no) 1994-12-19
TW202390B (fr) 1993-03-21
GR3015714T3 (en) 1995-07-31
FI95777B (fi) 1995-12-15
PT93991A (pt) 1991-02-08
RU2053766C1 (ru) 1996-02-10
DK0397147T3 (da) 1995-03-20
CN1047204A (zh) 1990-11-28
JPH0643437B2 (ja) 1994-06-08
DE69016087T2 (de) 1995-05-24
ATE117313T1 (de) 1995-02-15
EP0397147A2 (fr) 1990-11-14
FI95777C (fi) 1996-03-25
HU902989D0 (en) 1990-09-28
IE66515B1 (en) 1996-01-10
CZ283416B6 (cs) 1998-04-15
KR900017596A (ko) 1990-12-19
AU5482390A (en) 1990-11-15
EP0397147B1 (fr) 1995-01-18
YU90490A (en) 1991-10-31
HUT54053A (en) 1991-01-28
NO176390C (no) 1995-03-29
IE901687L (en) 1990-11-10
HU206627B (en) 1992-12-28
NO902048D0 (no) 1990-05-09
PT93991B (pt) 1996-11-29
EG19218A (en) 1994-10-30
CZ225590A3 (en) 1997-12-17
DE69016087D1 (de) 1995-03-02
JPH0317094A (ja) 1991-01-25
NO902048L (no) 1990-11-12
FI902276A0 (fi) 1990-05-07
KR920004098B1 (ko) 1992-05-25

Similar Documents

Publication Publication Date Title
NZ234143A (en) Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
ES8303091A1 (es) Un procedimiento para la preparacion de una nueva formulacion de bacampicilina.
SE8603582L (sv) Komposition innehallande l-dopa
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
FI843286A0 (fi) Stabil, sur vattenloesning av cis-platina laemplig foer injektion.
EG19218A (en) Stable solutions of rebeccamycin analogs and preparation thereof
IL83086A0 (en) Stable,injectable solutions of vinca dimer salts
GR3002835T3 (en) Pharmaceutical compositions containing pentamidine
DK443988A (da) Injektionspraeparat indeholdende modificeret tpa
IT1260996B (it) Fiala a soluzione per infusione di acido tiottico in forma di sale idrosolubile dell'acido tiottico.
MX9703839A (es) Soluciones intravenosas de lubeluzol.
MY104606A (en) Aqueous high concentration composition of alpha-sulfofa -tty acid ester salt.
MY107599A (en) Sucralfate suspension compounds.
TH5472A (th) การเตรียมเพพไทด์
TH5472EX (th) การเตรียมเพพไทด์